HPCM
Hunter Perkins Capital Management Portfolio holdings
AUM
$420M
This Quarter Return
+8.43%
1 Year Return
+9.26%
3 Year Return
+31.93%
5 Year Return
+91.65%
10 Year Return
–
AUM
$488M
AUM Growth
+$488M
(+2%)
Cap. Flow
-$26.8M
Cap. Flow
% of AUM
-5.5%
Top 10 Holdings %
Top 10 Hldgs %
39.09%
Holding
115
New
26
Increased
25
Reduced
49
Closed
9
Top Buys
| 1 |
EOG Resources
EOG
|
$8.66M |
| 2 |
Polaris
PII
|
$6.25M |
| 3 |
Vishay Intertechnology
VSH
|
$5.96M |
| 4 |
Simpson Manufacturing
SSD
|
$1.34M |
| 5 |
Lazard
LAZ
|
$1.23M |
Top Sells
| 1 |
Canadian Pacific Kansas City
CP
|
$11.1M |
| 2 |
Walt Disney
DIS
|
$5.12M |
| 3 |
Kroger
KR
|
$4.43M |
| 4 |
LKQ Corp
LKQ
|
$3.53M |
| 5 |
Hanover Insurance
THG
|
$3.2M |
Sector Composition
| 1 | Financials | 20.29% |
| 2 | Healthcare | 17.16% |
| 3 | Consumer Discretionary | 14.71% |
| 4 | Technology | 12.48% |
| 5 | Real Estate | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PML
101
PIMCO Municipal Income Fund II
PML
$483M
| $227K | 0.05% | 26,640 | – | – |
|
|
RMT
102
Royce Micro-Cap Trust
RMT
$535M
| $155K | 0.03% | 16,351 | – | – |
|
103
Zymeworks
ZYME
$1.12B
| $116K | 0.02% | 11,033 +843 | +8% | +$8.86K |
|
104
Nuvation Bio
NUVB
$1.02B
| $84K | 0.02% | 23,000 | – | – |
|
105
Mersana Therapeutics
MRSN
$36.5M
| $67K | 0.01% | 15,000 -10,700 | -42% | -$47.8K |
|
106
ATAI Life Sciences
ATAI
$982M
| $38K | 0.01% | 19,241 | – | – |
|
107
Ball Corp
BALL
$14.3B
| – | – | -40,000 | Closed | -$2.3M |
|
108
Capital One
COF
$145B
| – | – | -10,000 | Closed | -$1.31M |
|
109
Costco
COST
$418B
| – | – | -4,000 | Closed | -$2.7M |
|
110
Hormel Foods
HRL
$14B
| – | – | -10,000 | Closed | -$321K |
|
111
Kaiser Aluminum
KALU
$1.26B
| – | – | -15,000 | Closed | -$1.07M |
|
112
Liberty Broadband Class C
LBRDK
$8.73B
| – | – | -19,800 | Closed | -$1.6M |
|
113
Open Text
OTEX
$8.41B
| – | – | -15,000 | Closed | -$630K |
|
114
Restaurant Brands International
QSR
$20.8B
| – | – | -10,000 | Closed | -$781K |
|
115
Thermo Fisher Scientific
TMO
$186B
| – | – | -5,000 | Closed | -$2.65M |
|